Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 2
1988 1
1989 1
1990 2
1991 2
1992 2
1995 1
1996 2
1997 1
1999 1
2000 3
2001 2
2003 2
2004 2
2005 2
2006 2
2007 4
2008 2
2009 6
2010 6
2011 5
2012 2
2013 4
2014 3
2015 7
2016 5
2017 4
2018 4
2019 3
2020 3
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
Neuroprotective agents: cannabinoids.
Sánchez AJ, García-Merino A. Sánchez AJ, et al. Among authors: garcia merino a. Clin Immunol. 2012 Jan;142(1):57-67. doi: 10.1016/j.clim.2011.02.010. Epub 2011 Mar 21. Clin Immunol. 2012. PMID: 21420365 Review.
Multidisciplinary Management of the Adverse Effects of Apremilast.
Daudén Tello E, Alonso Suárez J, Beltrán Catalán E, Blasco Maldonado C, Herrero Manso MC, Jiménez Morales A, Marín-Jiménez I, Martín-Arranz MD, García-Merino A, Porta Etessam J, Rodríguez-Sagrado MA, Rosas Gómez de Salazar J, Trujillo Martín E, Salgado-Boquete L. Daudén Tello E, et al. Among authors: garcia merino a. Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):134-141. doi: 10.1016/j.ad.2020.08.007. Epub 2020 Sep 7. Actas Dermosifiliogr (Engl Ed). 2021. PMID: 32910923 Free article. English, Spanish.
Monoclonal antibodies. Basic features.
García Merino A. García Merino A. Neurologia. 2011 Jun;26(5):301-6. doi: 10.1016/j.nrl.2010.10.005. Epub 2010 Dec 28. Neurologia. 2011. PMID: 21193249 Free article. Review. English, Spanish.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Moreno Torres I, García-Merino A. Moreno Torres I, et al. Among authors: garcia merino a. Expert Rev Neurother. 2017 Apr;17(4):359-371. doi: 10.1080/14737175.2017.1245616. Epub 2016 Oct 21. Expert Rev Neurother. 2017. PMID: 27718747 Review.
Confirming the MS diagnosis.
Garcia Merino A, Blasco MR. Garcia Merino A, et al. Int MS J. 2007 Jun;14(2):58-63. Int MS J. 2007. PMID: 17686345 Review.
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.
Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Platas M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X. Meca-Lallana JE, et al. Among authors: garcia merino a. Neurologia (Engl Ed). 2020 Jan 25:S0213-4853(19)30146-X. doi: 10.1016/j.nrl.2019.11.003. Online ahead of print. Neurologia (Engl Ed). 2020. PMID: 31987648 English, Spanish.
Perception of stigma in patients with primary progressive multiple sclerosis.
Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B. Pérez-Miralles F, et al. Among authors: garcia merino a. Mult Scler J Exp Transl Clin. 2019 May 22;5(2):2055217319852717. doi: 10.1177/2055217319852717. eCollection 2019 Apr-Jun. Mult Scler J Exp Transl Clin. 2019. PMID: 31205741 Free PMC article.
75 results